Home » Authors » Amanda Pedersen

Amanda Pedersen

Articles

ARTICLES

Impulse completes enrollment in Optimizer III FIX-HF-5 trial

June 8, 2007

By Amanda Pedersen

DexCom’s Seven is next step in continuous glucose monitoring

June 7, 2007

By Amanda Pedersen

New ventures: Endovasc creates BioFlow unit to develop biodegradable stents

June 7, 2007

By Amanda Pedersen

Agreements: Cardio3 BioSciences partners with Mayo Clinic for stem cell research

June 7, 2007

By Amanda Pedersen

ev3 to study EverFlex stent for treatment of PAD under an IDE

June 6, 2007

By Amanda Pedersen

AMO to focus on rub solutions In wake of Moisture Plus recall

June 6, 2007

By Amanda Pedersen

DexCom s Seven is next step in continuous glucose monitoring

June 4, 2007

By Amanda Pedersen

Flo 24 trial extends treatment for Ischemic stroke up to 24 hours

June 4, 2007

By Amanda Pedersen

Acorn gets FDA okay for new trial of CorCap device

June 1, 2007

By Amanda Pedersen

MIS need for OSA therapy fuels strong response to Aspire trial

May 29, 2007

By Amanda Pedersen

View All Articles by Amanda Pedersen

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...